CJ CheilJedang sold 1.03 trillion won worth of Bibigo dumplings in 2020, with 65 percent generated from overseas.
This year’s sales were double that of the 506 billion won in 2017.
The US was the biggest market for Bibigo dumplings, recording sales of 420 billion won this year. China was second with 160 billion won, followed by Japan with 65 billion won.
Global sales first surpassed local sales in 2018.
According to CJ, it made efforts to get rid of the negative perceptions of frozen food to improve its image locally.
To boost sales in overseas markets, the company analyzed the different eating cultures and consumption patterns.
CJ also said it has invested to expand its production bases, from five in South Korea, the US, and China, to 15, including in Vietnam, Japan, and Germany.
The company's main target markets in Europe were the UK, France, and Germany, which are familiar with Asian cuisines. In the three countries, the company recorded a 61 percent average annual growth rate in the past three years.
According to a CJ CheilJedang official, their vision of people in the world having Korean food once a week has been realized.


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



